NI
OCUL icon

Numeric Investors’s Ocular Therapeutix OCUL Stock Holding History

Numeric Investors’s Portfolio OCUL Stock Details OCUL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-14,400
Closed -$135K – 1089
2015
Q4 		$135K Buy
+14,400
New +$155K ﹤0.01% 943
2015
Q1 		– Sell
-27,802
Closed -$654K – 988
2014
Q4 		$654K Buy
+27,802
New +$468K 0.01% 547

Other funds holding OCUL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
SHI
SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Numeric Investors's OCUL Position: Q1 2016 in Review

Numeric Investors sold out of Ocular Therapeutix (OCUL) in Q1 2016, closing a stake of 14,400 shares — an estimated $135K sold.

Numeric Investors first reported a position in OCUL in Q4 2014 and held it in 2 quarters. The position peaked at $654K in Q4 2014. 64 funds tracked by Wall St. Rank hold OCUL as of Q1 2016.

  • Numeric Investors reported no remaining Ocular Therapeutix position as of Q1 2016 after selling out during the quarter.
  • Numeric Investors sold 14,400 Ocular Therapeutix shares in Q1 2016, an estimated $135K.
  • Numeric Investors first reported a position in Ocular Therapeutix in Q4 2014 and held it in 2 quarters.
  • Numeric Investors's Ocular Therapeutix position peaked at $654K in Q4 2014.
  • 64 funds tracked by Wall St. Rank held Ocular Therapeutix as of Q1 2016.

Based on Numeric Investors's 13F filing for Q1 2016, filed 6 May 2016.